Early-onset lichenoid graft-vs.-host disease: a unique variant of acute graft-vs.-host disease occurring in peripheral blood stem cell transplant recipients

被引:1
|
作者
Magro, Cynthia M. [1 ]
Kerns, Mary Jo [2 ]
Votava, Henry [3 ]
Vasil, Katherine E. [4 ]
Dyrsen, Molly E. [1 ]
Morrison, Carl D. [5 ]
机构
[1] Cornell Univ, Weill Med Coll, New York, NY 10065 USA
[2] Univ Cincinnati, Dept Dermatol Cincinnatti, Cincinnati, OH 45221 USA
[3] NYU, Med Ctr, Div Dermatopathol, New York, NY 10016 USA
[4] Riverside Methodist Hosp, Columbus, OH 43214 USA
[5] Roswell Pk Canc Inst, Buffalo, NY USA
关键词
BONE-MARROW-TRANSPLANTATION; TOXIC EPIDERMAL NECROLYSIS; INCLUSION-BODY CHANGE; PATHOPHYSIOLOGY; MANIFESTATIONS; DIFFERENTIATE; MANAGEMENT; SPECTRUM; LESIONS; INJURY;
D O I
10.1111/j.1600-0560.2009.01427.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: A complication of stem cell transplantation is chronic graft-vs.-host disease (GvHD), developing months to years after transplant; the two commonest manifestations are lichenoid GvHD and scleroderma. The purpose of this study was to characterize early-onset lichenoid GvHD. Methods: A retrospective study identified patients diagnosed with early-onset lichenoid GvHD. This diagnosis was correlated with type of transplant and concurrent or prior episodes of acute GvHD. Results: Patients in whom a sex mismatch was present between donor and recipient were included, representing a study population of 17. All received an allogeneic peripheral blood stem cell transplant (PBSCT). All patients had biopsy proven lichenoid GvHD within 60 days or less following transplantation. All had concurrent gastrointestinal symptoms which was biopsy proven GvHD in thirteen of the cases. FISH XY studies revealed that the infiltrating lymphocytes were of donor origin in 12 of the cases, mixed in three and of host origin in two cases. Conclusions: Early-onset lichenoid GvHD is exclusive to the PBSCT setting and appears to be mediated by donor lymphocytes, reflecting the higher numbers of donor T cells encountered in PBSCT. We consider this reaction pattern a distinctive subtype of acute GvHD.
引用
收藏
页码:549 / 558
页数:10
相关论文
共 50 条
  • [31] The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease
    Bastian, David
    Wu, Yongxia
    Betts, Brian C.
    Yu, Xue-Zhong
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [32] Acral verruca-like presentation of chronic graft-vs.-host disease
    Park, Joyce H.
    Lester, Laura
    Kim, Jinah
    Kwong, Bernice Y.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (03) : 236 - 241
  • [33] Quantitative analysis of Langerhans' cells in oral chronic graft-vs.-host disease
    Lenharo Orti-Raduan, Erika Sinara
    Ferreira Nunes, Adauto Jose
    Oliveira, Denise Tostes
    Lara, Vanessa Soares
    de Assis Taveira, Luis Antonio
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2009, 38 (01) : 132 - 137
  • [34] Late effects of chronic graft-vs.-host disease in minor salivary glands
    Alborghetti, MR
    Corrêa, MEP
    Adam, RL
    Metze, K
    Coracin, FL
    de Souza, CA
    Cintra, ML
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2005, 34 (08) : 486 - 493
  • [35] Epithelioid granulomas in post-transplantation chronic graft-vs.-host disease
    Tsunemi, Y
    Ihn, H
    Saeki, H
    Tamaki, K
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (04) : 898 - 899
  • [36] Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease
    Marcoux, Curtis M.
    Alousi, Amin M.
    Im, Jin
    Hill, Laquisa C.
    Smallbone, Portia
    Popat, Uday
    Hosing, Chitra
    Kebriaei, Partow
    Olson, Amanda
    Mehta, Rohtesh
    Chen, George
    Qazilbash, Muzaffar
    Shpall, Elizabeth
    Champlin, Richard C.
    Saliba, Rima M.
    BONE MARROW TRANSPLANTATION, 2024, 59 (11) : 1594 - 1600
  • [37] Acute Graft-vs.-Host Disease-Associated Endothelial Activation in vitro Is Prevented by Defibrotide
    Martinez-Sanchez, Julia
    Hamelmann, Hannah
    Palomo, Marta
    Mir, Enrique
    Belen Moreno-Castano, Ana
    Torramade, Sergi
    Rovira, Montserrat
    Escolar, Gines
    Cordes, Steffen
    Kalupa, Martina
    Mertlitz, Sarah
    Riesner, Katarina
    Carreras, Enric
    Penack, Olaf
    Diaz-Ricart, Maribel
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [38] Steroid-refractory graft-vs.-host disease: past, present and future
    Carpenter, PA
    Sanders, JE
    PEDIATRIC TRANSPLANTATION, 2003, 7 : 19 - 31
  • [39] Quantitative analysis of eosinophils in acute graft-vs.-host disease compared to drug hypersensitivity reactions
    Weaver, J.
    Bergfeld, W.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2007, 34 (01) : 137 - 137
  • [40] Oral Chronic Graft-vs.-Host Disease Characterization Using the NIH Scale
    Fassil, H.
    Bassim, C. W.
    Mays, J.
    Edwards, D.
    Baird, K.
    Steinberg, S. M.
    Williams, K. M.
    Cowen, E. W.
    Mitchell, S. A.
    Hakim, F. T.
    Taylor, T.
    Avila, D.
    Zhang, D.
    Grkovic, L.
    Datiles, M.
    Gress, R. E.
    Pavletic, S. Z.
    JOURNAL OF DENTAL RESEARCH, 2012, 91 (07) : S45 - S51